A Study of PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma

NCT01852799 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: PAD Followed by ASCT

Sponsor

Shanghai Changzheng Hospital